Clinical Studies Bios Life Sprecher DL, Pearce GL (2002) Fiber-multivitamin combination therapy: a beneficial influence on low density lipoprotein and homocysteine Metabolism 51, 1166-70. Freed S, Joffe D (2000) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes Diabetes in Control 12-8. Freed S, Joffe D (2004) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes II Diabetes in Control 212, 17, and Verdegem P, Freed S, Joffe D (2005) The clinical impact of fiber supplementation for the reduction of postprandial blood blucose and reduction of complications from type-2 diabetes Diabetes 54, A425. Balajadia E, Valerio A, Yumul N. Beneficial effects of Bios Life 2 (Dietary Fiber Supplement) in patients with dyslipidemia. in 34th Annual Convention of the Philippine College of Physicians. 2004. Verdegem P (2007) Viscous soluble fiber combined with phytosterols and policosanol reduces LDL-c and increases HDL-c in hypercholesterolemia Current Topics in Neutraceutical Research. Verdegem P, Duenas V, Duenas J, Burke E. LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong. 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy. Duenas V, Duenas J, Burke E, Verdegem P (2006) A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia Arterioscler Thromb Vasc Biol 26, e53-e107. Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes in 6th International Conference on Atherosclerosis, Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results. Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Type-2 Diabetes. in 65th Scientific Session American Diabetes Association. 2005. San Diego, CA, USA. Cardio Essentials Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction: Farida Jeejeebhoy, MD, Mary Keith, PhD, Michael Freeman, MD, Aiala Barr, PhD, Michele McCall, MSc, RD, Regina Kurian, BSc, David Mazer, MD, and Lee Errett, MD, Am Heart J 2002;143:1092-100. (the product MyoVive is marketed by our previous parent company and has the same ingredients as Cardio Essentials) Cellular Essentials Nutritional Supplement Program Halts Progression of Early Coronary Atherosclerosis Documented by Ultrafast Computed Tomography Journal of Applied Nutrition 1996, 48: 67-78. 7th Conference on Arteriosclerosis, Thrombosis and Vascular Biology, 2005, Washington, DC CM Plex Effect of a Cetylated Fatty Acid Topical Cream on Functional Mobility and Quality of Life of Patients with Osteoarthritis William J. Kraemer, Nicholas A. Ratamess, Jeffrey M. Anderson, Carl M. Maresh, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Duncan N. French, Matthew J. Sharman, Martyn R. Rubin, Aan L. Gomez, Jeff S. Volek, and Robert L. Hesslink Jr., J Rheumatol 2004;31:767–74 Cetylated Fatty Acids Improve Knee Function in Patients with Osteoarthritis. Robert Hesslink Jr., David Armstrong III, M.V. Nagendran, Srinan Sreevatsan, and Raj Barathur J. Rheumatol 2002;29:1708-12. DP24 2004 Experimental Biology meeting by J.C. Young et al. with title “The Effect of Soluble Fiber on Glucose Tolerance and Antioxidant Status in Insulin-Resistance Rats”
